nodes	percent_of_prediction	percent_of_DWPC	metapath
Raltitrexed—Methotrexate—breast cancer	0.307	1	CrCtD
Raltitrexed—TYMS—breast cancer	0.163	1	CbGaD
Raltitrexed—TYMS—Capecitabine—breast cancer	0.061	0.283	CbGbCtD
Raltitrexed—FPGS—Methotrexate—breast cancer	0.0564	0.261	CbGbCtD
Raltitrexed—TYMS—Gemcitabine—breast cancer	0.0423	0.196	CbGbCtD
Raltitrexed—Tetrahydrofolic acid—Methotrexate—breast cancer	0.0405	0.2	CrCrCtD
Raltitrexed—Leucovorin—Methotrexate—breast cancer	0.0405	0.2	CrCrCtD
Raltitrexed—Folic Acid—Methotrexate—breast cancer	0.0405	0.2	CrCrCtD
Raltitrexed—Pralatrexate—Methotrexate—breast cancer	0.0405	0.2	CrCrCtD
Raltitrexed—Pemetrexed—Methotrexate—breast cancer	0.0405	0.2	CrCrCtD
Raltitrexed—TYMS—Fluorouracil—breast cancer	0.0362	0.168	CbGbCtD
Raltitrexed—TYMS—Methotrexate—breast cancer	0.0199	0.0924	CbGbCtD
Raltitrexed—FPGS—nipple—breast cancer	0.00148	0.119	CbGeAlD
Raltitrexed—FPGS—skin of body—breast cancer	0.000948	0.0763	CbGeAlD
Raltitrexed—FPGS—endometrium—breast cancer	0.000894	0.0719	CbGeAlD
Raltitrexed—FPGS—pituitary gland—breast cancer	0.000809	0.0651	CbGeAlD
Raltitrexed—FPGS—adipose tissue—breast cancer	0.000806	0.0648	CbGeAlD
Raltitrexed—FPGS—female reproductive system—breast cancer	0.00074	0.0596	CbGeAlD
Raltitrexed—FPGS—adrenal gland—breast cancer	0.000723	0.0582	CbGeAlD
Raltitrexed—FPGS—female gonad—breast cancer	0.000674	0.0542	CbGeAlD
Raltitrexed—FPGS—endocrine gland—breast cancer	0.000627	0.0504	CbGeAlD
Raltitrexed—TYMS—skin of body—breast cancer	0.000622	0.05	CbGeAlD
Raltitrexed—TYMS—endometrium—breast cancer	0.000586	0.0472	CbGeAlD
Raltitrexed—TYMS—adipose tissue—breast cancer	0.000528	0.0425	CbGeAlD
Raltitrexed—Tetrahydrofolic acid—SHMT1—breast cancer	0.000523	0.265	CrCbGaD
Raltitrexed—TYMS—female reproductive system—breast cancer	0.000486	0.0391	CbGeAlD
Raltitrexed—TYMS—adrenal gland—breast cancer	0.000474	0.0381	CbGeAlD
Raltitrexed—TYMS—bone marrow—breast cancer	0.000459	0.0369	CbGeAlD
Raltitrexed—TYMS—female gonad—breast cancer	0.000442	0.0356	CbGeAlD
Raltitrexed—FPGS—lymph node—breast cancer	0.000433	0.0349	CbGeAlD
Raltitrexed—TYMS—endocrine gland—breast cancer	0.000411	0.0331	CbGeAlD
Raltitrexed—TYMS—Docetaxel—Paclitaxel—breast cancer	0.000305	0.226	CbGdCrCtD
Raltitrexed—TYMS—Gefitinib—Lapatinib—breast cancer	0.000299	0.222	CbGdCrCtD
Raltitrexed—TYMS—lymph node—breast cancer	0.000284	0.0229	CbGeAlD
Raltitrexed—Tetrahydrofolic acid—MTR—breast cancer	0.000268	0.136	CrCbGaD
Raltitrexed—Pralatrexate—TYMS—breast cancer	0.000179	0.0905	CrCbGaD
Raltitrexed—Leucovorin—TYMS—breast cancer	0.000179	0.0905	CrCbGaD
Raltitrexed—TYMS—Paclitaxel—Docetaxel—breast cancer	0.000152	0.113	CbGdCrCtD
Raltitrexed—Pemetrexed—TYMS—breast cancer	0.000143	0.0723	CrCbGaD
Raltitrexed—Methotrexate—SLCO1B1—breast cancer	0.00011	0.0558	CrCbGaD
Raltitrexed—TYMS—Vincristine—Vinorelbine—breast cancer	0.000104	0.0775	CbGdCrCtD
Raltitrexed—TYMS—Vinorelbine—Vinblastine—breast cancer	9.77e-05	0.0725	CbGdCrCtD
Raltitrexed—Folic Acid—MTHFR—breast cancer	9.15e-05	0.0464	CrCbGaD
Raltitrexed—Tetrahydrofolic acid—MTHFR—breast cancer	9.15e-05	0.0464	CrCbGaD
Raltitrexed—Methotrexate—ABCC1—breast cancer	9.1e-05	0.0461	CrCbGaD
Raltitrexed—TYMS—Vinblastine—Vinorelbine—breast cancer	8.4e-05	0.0623	CbGdCrCtD
Raltitrexed—TYMS—Vincristine—Vinblastine—breast cancer	8.35e-05	0.062	CbGdCrCtD
Raltitrexed—Methotrexate—TYMS—breast cancer	7.87e-05	0.0399	CrCbGaD
Raltitrexed—Folic Acid—ABCG2—breast cancer	7.01e-05	0.0355	CrCbGaD
Raltitrexed—TYMS—Clobetasol propionate—Fluoxymesterone—breast cancer	6.73e-05	0.0499	CbGdCrCtD
Raltitrexed—TYMS—Triamcinolone—Fluoxymesterone—breast cancer	6.57e-05	0.0487	CbGdCrCtD
Raltitrexed—Methotrexate—MTHFR—breast cancer	6.26e-05	0.0317	CrCbGaD
Raltitrexed—TYMS—Danazol—Fluoxymesterone—breast cancer	5.09e-05	0.0377	CbGdCrCtD
Raltitrexed—Methotrexate—ABCG2—breast cancer	4.79e-05	0.0243	CrCbGaD
Raltitrexed—TYMS—Azacitidine—Gemcitabine—breast cancer	3.94e-05	0.0292	CbGdCrCtD
Raltitrexed—Constipation—Gemcitabine—breast cancer	3.33e-05	0.000572	CcSEcCtD
Raltitrexed—Decreased appetite—Fluorouracil—breast cancer	3.33e-05	0.000572	CcSEcCtD
Raltitrexed—Alopecia—Capecitabine—breast cancer	3.33e-05	0.000572	CcSEcCtD
Raltitrexed—Asthenia—Thiotepa—breast cancer	3.32e-05	0.000571	CcSEcCtD
Raltitrexed—Diarrhoea—Vinorelbine—breast cancer	3.32e-05	0.00057	CcSEcCtD
Raltitrexed—Dysgeusia—Docetaxel—breast cancer	3.32e-05	0.00057	CcSEcCtD
Raltitrexed—Nausea—Melphalan—breast cancer	3.3e-05	0.000566	CcSEcCtD
Raltitrexed—Feeling abnormal—Mitoxantrone—breast cancer	3.3e-05	0.000566	CcSEcCtD
Raltitrexed—Feeling abnormal—Irinotecan—breast cancer	3.3e-05	0.000566	CcSEcCtD
Raltitrexed—Neutropenia—Methotrexate—breast cancer	3.28e-05	0.000563	CcSEcCtD
Raltitrexed—Pruritus—Thiotepa—breast cancer	3.28e-05	0.000563	CcSEcCtD
Raltitrexed—Pain—Fluorouracil—breast cancer	3.27e-05	0.000563	CcSEcCtD
Raltitrexed—Gastrointestinal pain—Mitoxantrone—breast cancer	3.27e-05	0.000562	CcSEcCtD
Raltitrexed—Gastrointestinal pain—Irinotecan—breast cancer	3.27e-05	0.000562	CcSEcCtD
Raltitrexed—Dehydration—Doxorubicin—breast cancer	3.26e-05	0.000561	CcSEcCtD
Raltitrexed—Oedema—Paclitaxel—breast cancer	3.26e-05	0.00056	CcSEcCtD
Raltitrexed—Infection—Paclitaxel—breast cancer	3.24e-05	0.000556	CcSEcCtD
Raltitrexed—Nausea—Goserelin—breast cancer	3.22e-05	0.000552	CcSEcCtD
Raltitrexed—Dysgeusia—Capecitabine—breast cancer	3.21e-05	0.000552	CcSEcCtD
Raltitrexed—Feeling abnormal—Gemcitabine—breast cancer	3.21e-05	0.000551	CcSEcCtD
Raltitrexed—Thrombocytopenia—Paclitaxel—breast cancer	3.19e-05	0.000548	CcSEcCtD
Raltitrexed—Diarrhoea—Thiotepa—breast cancer	3.17e-05	0.000544	CcSEcCtD
Raltitrexed—Abdominal pain—Mitoxantrone—breast cancer	3.16e-05	0.000543	CcSEcCtD
Raltitrexed—Body temperature increased—Irinotecan—breast cancer	3.16e-05	0.000543	CcSEcCtD
Raltitrexed—Abdominal pain—Irinotecan—breast cancer	3.16e-05	0.000543	CcSEcCtD
Raltitrexed—Body temperature increased—Mitoxantrone—breast cancer	3.16e-05	0.000543	CcSEcCtD
Raltitrexed—Feeling abnormal—Fluorouracil—breast cancer	3.16e-05	0.000542	CcSEcCtD
Raltitrexed—Hyperhidrosis—Paclitaxel—breast cancer	3.15e-05	0.000541	CcSEcCtD
Raltitrexed—Anaemia—Docetaxel—breast cancer	3.13e-05	0.000538	CcSEcCtD
Raltitrexed—Anorexia—Paclitaxel—breast cancer	3.11e-05	0.000534	CcSEcCtD
Raltitrexed—Vomiting—Vinorelbine—breast cancer	3.08e-05	0.000529	CcSEcCtD
Raltitrexed—Body temperature increased—Gemcitabine—breast cancer	3.08e-05	0.000529	CcSEcCtD
Raltitrexed—Renal failure—Methotrexate—breast cancer	3.07e-05	0.000527	CcSEcCtD
Raltitrexed—Neutropenia—Epirubicin—breast cancer	3.07e-05	0.000527	CcSEcCtD
Raltitrexed—Rash—Vinorelbine—breast cancer	3.06e-05	0.000525	CcSEcCtD
Raltitrexed—Dermatitis—Vinorelbine—breast cancer	3.05e-05	0.000525	CcSEcCtD
Raltitrexed—Stomatitis—Methotrexate—breast cancer	3.04e-05	0.000523	CcSEcCtD
Raltitrexed—Ill-defined disorder—Capecitabine—breast cancer	3.04e-05	0.000523	CcSEcCtD
Raltitrexed—Headache—Vinorelbine—breast cancer	3.04e-05	0.000522	CcSEcCtD
Raltitrexed—Conjunctivitis—Methotrexate—breast cancer	3.04e-05	0.000522	CcSEcCtD
Raltitrexed—Leukopenia—Docetaxel—breast cancer	3.03e-05	0.000521	CcSEcCtD
Raltitrexed—Anaemia—Capecitabine—breast cancer	3.03e-05	0.000521	CcSEcCtD
Raltitrexed—Body temperature increased—Fluorouracil—breast cancer	3.03e-05	0.00052	CcSEcCtD
Raltitrexed—Sweating—Methotrexate—breast cancer	2.99e-05	0.000514	CcSEcCtD
Raltitrexed—Musculoskeletal discomfort—Paclitaxel—breast cancer	2.97e-05	0.00051	CcSEcCtD
Raltitrexed—Weight decreased—Epirubicin—breast cancer	2.97e-05	0.000509	CcSEcCtD
Raltitrexed—Malaise—Capecitabine—breast cancer	2.96e-05	0.000508	CcSEcCtD
Raltitrexed—Cough—Docetaxel—breast cancer	2.96e-05	0.000508	CcSEcCtD
Raltitrexed—Vomiting—Thiotepa—breast cancer	2.94e-05	0.000506	CcSEcCtD
Raltitrexed—Leukopenia—Capecitabine—breast cancer	2.94e-05	0.000504	CcSEcCtD
Raltitrexed—Rash—Thiotepa—breast cancer	2.92e-05	0.000501	CcSEcCtD
Raltitrexed—Dermatitis—Thiotepa—breast cancer	2.92e-05	0.000501	CcSEcCtD
Raltitrexed—Headache—Thiotepa—breast cancer	2.9e-05	0.000498	CcSEcCtD
Raltitrexed—Arthralgia—Docetaxel—breast cancer	2.88e-05	0.000495	CcSEcCtD
Raltitrexed—Nausea—Vinorelbine—breast cancer	2.88e-05	0.000495	CcSEcCtD
Raltitrexed—Renal failure—Epirubicin—breast cancer	2.87e-05	0.000494	CcSEcCtD
Raltitrexed—Dyspepsia—Paclitaxel—breast cancer	2.87e-05	0.000493	CcSEcCtD
Raltitrexed—Asthenia—Mitoxantrone—breast cancer	2.87e-05	0.000493	CcSEcCtD
Raltitrexed—Asthenia—Irinotecan—breast cancer	2.87e-05	0.000493	CcSEcCtD
Raltitrexed—Cough—Capecitabine—breast cancer	2.86e-05	0.000491	CcSEcCtD
Raltitrexed—Stomatitis—Epirubicin—breast cancer	2.85e-05	0.000489	CcSEcCtD
Raltitrexed—Conjunctivitis—Epirubicin—breast cancer	2.84e-05	0.000488	CcSEcCtD
Raltitrexed—Neutropenia—Doxorubicin—breast cancer	2.84e-05	0.000487	CcSEcCtD
Raltitrexed—Decreased appetite—Paclitaxel—breast cancer	2.83e-05	0.000487	CcSEcCtD
Raltitrexed—Sweating—Epirubicin—breast cancer	2.8e-05	0.000481	CcSEcCtD
Raltitrexed—Asthenia—Gemcitabine—breast cancer	2.79e-05	0.00048	CcSEcCtD
Raltitrexed—Arthralgia—Capecitabine—breast cancer	2.79e-05	0.00048	CcSEcCtD
Raltitrexed—Constipation—Paclitaxel—breast cancer	2.79e-05	0.000479	CcSEcCtD
Raltitrexed—Pain—Paclitaxel—breast cancer	2.79e-05	0.000479	CcSEcCtD
Raltitrexed—Oedema—Docetaxel—breast cancer	2.76e-05	0.000475	CcSEcCtD
Raltitrexed—Discomfort—Capecitabine—breast cancer	2.76e-05	0.000474	CcSEcCtD
Raltitrexed—Pruritus—Gemcitabine—breast cancer	2.76e-05	0.000473	CcSEcCtD
Raltitrexed—Nausea—Thiotepa—breast cancer	2.75e-05	0.000472	CcSEcCtD
Raltitrexed—Infection—Docetaxel—breast cancer	2.75e-05	0.000472	CcSEcCtD
Raltitrexed—Weight decreased—Doxorubicin—breast cancer	2.74e-05	0.000471	CcSEcCtD
Raltitrexed—Diarrhoea—Mitoxantrone—breast cancer	2.74e-05	0.00047	CcSEcCtD
Raltitrexed—Diarrhoea—Irinotecan—breast cancer	2.74e-05	0.00047	CcSEcCtD
Raltitrexed—Pruritus—Fluorouracil—breast cancer	2.71e-05	0.000465	CcSEcCtD
Raltitrexed—Thrombocytopenia—Docetaxel—breast cancer	2.71e-05	0.000465	CcSEcCtD
Raltitrexed—Feeling abnormal—Paclitaxel—breast cancer	2.69e-05	0.000462	CcSEcCtD
Raltitrexed—Oedema—Capecitabine—breast cancer	2.68e-05	0.00046	CcSEcCtD
Raltitrexed—Gastrointestinal pain—Paclitaxel—breast cancer	2.67e-05	0.000458	CcSEcCtD
Raltitrexed—Diarrhoea—Gemcitabine—breast cancer	2.67e-05	0.000458	CcSEcCtD
Raltitrexed—Renal failure—Doxorubicin—breast cancer	2.66e-05	0.000457	CcSEcCtD
Raltitrexed—Infection—Capecitabine—breast cancer	2.66e-05	0.000457	CcSEcCtD
Raltitrexed—Stomatitis—Doxorubicin—breast cancer	2.64e-05	0.000453	CcSEcCtD
Raltitrexed—Anorexia—Docetaxel—breast cancer	2.63e-05	0.000453	CcSEcCtD
Raltitrexed—Conjunctivitis—Doxorubicin—breast cancer	2.63e-05	0.000452	CcSEcCtD
Raltitrexed—Diarrhoea—Fluorouracil—breast cancer	2.62e-05	0.00045	CcSEcCtD
Raltitrexed—Thrombocytopenia—Capecitabine—breast cancer	2.62e-05	0.00045	CcSEcCtD
Raltitrexed—Sweating—Doxorubicin—breast cancer	2.59e-05	0.000445	CcSEcCtD
Raltitrexed—Hyperhidrosis—Capecitabine—breast cancer	2.59e-05	0.000444	CcSEcCtD
Raltitrexed—Body temperature increased—Paclitaxel—breast cancer	2.58e-05	0.000443	CcSEcCtD
Raltitrexed—Abdominal pain—Paclitaxel—breast cancer	2.58e-05	0.000443	CcSEcCtD
Raltitrexed—Anorexia—Capecitabine—breast cancer	2.55e-05	0.000438	CcSEcCtD
Raltitrexed—Vomiting—Mitoxantrone—breast cancer	2.54e-05	0.000437	CcSEcCtD
Raltitrexed—Vomiting—Irinotecan—breast cancer	2.54e-05	0.000437	CcSEcCtD
Raltitrexed—Rash—Irinotecan—breast cancer	2.52e-05	0.000433	CcSEcCtD
Raltitrexed—Rash—Mitoxantrone—breast cancer	2.52e-05	0.000433	CcSEcCtD
Raltitrexed—Dermatitis—Mitoxantrone—breast cancer	2.52e-05	0.000433	CcSEcCtD
Raltitrexed—Dermatitis—Irinotecan—breast cancer	2.52e-05	0.000433	CcSEcCtD
Raltitrexed—Musculoskeletal discomfort—Docetaxel—breast cancer	2.52e-05	0.000433	CcSEcCtD
Raltitrexed—Headache—Mitoxantrone—breast cancer	2.51e-05	0.00043	CcSEcCtD
Raltitrexed—Headache—Irinotecan—breast cancer	2.51e-05	0.00043	CcSEcCtD
Raltitrexed—Alopecia—Methotrexate—breast cancer	2.48e-05	0.000426	CcSEcCtD
Raltitrexed—Vomiting—Gemcitabine—breast cancer	2.48e-05	0.000425	CcSEcCtD
Raltitrexed—Rash—Gemcitabine—breast cancer	2.46e-05	0.000422	CcSEcCtD
Raltitrexed—Dermatitis—Gemcitabine—breast cancer	2.45e-05	0.000421	CcSEcCtD
Raltitrexed—Headache—Gemcitabine—breast cancer	2.44e-05	0.000419	CcSEcCtD
Raltitrexed—Musculoskeletal discomfort—Capecitabine—breast cancer	2.44e-05	0.000419	CcSEcCtD
Raltitrexed—Vomiting—Fluorouracil—breast cancer	2.44e-05	0.000418	CcSEcCtD
Raltitrexed—TYMS—Cell Cycle—RAD51—breast cancer	2.43e-05	0.000648	CbGpPWpGaD
Raltitrexed—Dyspepsia—Docetaxel—breast cancer	2.43e-05	0.000418	CcSEcCtD
Raltitrexed—FPGS—Disease—PRL—breast cancer	2.43e-05	0.000646	CbGpPWpGaD
Raltitrexed—TYMS—Metabolism—CHST9—breast cancer	2.42e-05	0.000644	CbGpPWpGaD
Raltitrexed—Rash—Fluorouracil—breast cancer	2.41e-05	0.000415	CcSEcCtD
Raltitrexed—Dermatitis—Fluorouracil—breast cancer	2.41e-05	0.000414	CcSEcCtD
Raltitrexed—FPGS—Metabolism—NCOA2—breast cancer	2.41e-05	0.000642	CbGpPWpGaD
Raltitrexed—Decreased appetite—Docetaxel—breast cancer	2.4e-05	0.000413	CcSEcCtD
Raltitrexed—Headache—Fluorouracil—breast cancer	2.4e-05	0.000412	CcSEcCtD
Raltitrexed—FPGS—Disease—ADAM10—breast cancer	2.39e-05	0.000637	CbGpPWpGaD
Raltitrexed—Dysgeusia—Methotrexate—breast cancer	2.39e-05	0.000411	CcSEcCtD
Raltitrexed—TYMS—Cell Cycle, Mitotic—TOP2A—breast cancer	2.38e-05	0.000633	CbGpPWpGaD
Raltitrexed—Nausea—Irinotecan—breast cancer	2.38e-05	0.000408	CcSEcCtD
Raltitrexed—Nausea—Mitoxantrone—breast cancer	2.38e-05	0.000408	CcSEcCtD
Raltitrexed—Constipation—Docetaxel—breast cancer	2.36e-05	0.000406	CcSEcCtD
Raltitrexed—Pain—Docetaxel—breast cancer	2.36e-05	0.000406	CcSEcCtD
Raltitrexed—Dyspepsia—Capecitabine—breast cancer	2.36e-05	0.000405	CcSEcCtD
Raltitrexed—TYMS—Mitotic G1-G1/S phases—CDKN1B—breast cancer	2.35e-05	0.000626	CbGpPWpGaD
Raltitrexed—Arrhythmia—Epirubicin—breast cancer	2.34e-05	0.000403	CcSEcCtD
Raltitrexed—Asthenia—Paclitaxel—breast cancer	2.34e-05	0.000402	CcSEcCtD
Raltitrexed—FPGS—Metabolism—FASN—breast cancer	2.34e-05	0.000623	CbGpPWpGaD
Raltitrexed—FPGS—Metabolism—BCHE—breast cancer	2.33e-05	0.00062	CbGpPWpGaD
Raltitrexed—Decreased appetite—Capecitabine—breast cancer	2.33e-05	0.0004	CcSEcCtD
Raltitrexed—FPGS—Disease—FGF10—breast cancer	2.33e-05	0.000619	CbGpPWpGaD
Raltitrexed—Alopecia—Epirubicin—breast cancer	2.32e-05	0.000398	CcSEcCtD
Raltitrexed—Nausea—Gemcitabine—breast cancer	2.31e-05	0.000397	CcSEcCtD
Raltitrexed—TYMS—Integrated Pancreatic Cancer Pathway—CASP8—breast cancer	2.31e-05	0.000614	CbGpPWpGaD
Raltitrexed—Pruritus—Paclitaxel—breast cancer	2.31e-05	0.000396	CcSEcCtD
Raltitrexed—FPGS—Metabolism—SLC5A5—breast cancer	2.3e-05	0.000612	CbGpPWpGaD
Raltitrexed—TYMS—Metabolism—COX11—breast cancer	2.29e-05	0.000611	CbGpPWpGaD
Raltitrexed—Pain—Capecitabine—breast cancer	2.29e-05	0.000393	CcSEcCtD
Raltitrexed—Constipation—Capecitabine—breast cancer	2.29e-05	0.000393	CcSEcCtD
Raltitrexed—Feeling abnormal—Docetaxel—breast cancer	2.28e-05	0.000391	CcSEcCtD
Raltitrexed—Nausea—Fluorouracil—breast cancer	2.27e-05	0.000391	CcSEcCtD
Raltitrexed—TYMS—Integrated Pancreatic Cancer Pathway—IGF1—breast cancer	2.27e-05	0.000604	CbGpPWpGaD
Raltitrexed—TYMS—Cell Cycle, Mitotic—AURKA—breast cancer	2.27e-05	0.000604	CbGpPWpGaD
Raltitrexed—Ill-defined disorder—Methotrexate—breast cancer	2.26e-05	0.000389	CcSEcCtD
Raltitrexed—Gastrointestinal pain—Docetaxel—breast cancer	2.26e-05	0.000388	CcSEcCtD
Raltitrexed—Anaemia—Methotrexate—breast cancer	2.26e-05	0.000388	CcSEcCtD
Raltitrexed—TYMS—Cell Cycle—NBN—breast cancer	2.25e-05	0.0006	CbGpPWpGaD
Raltitrexed—FPGS—Disease—PDGFA—breast cancer	2.24e-05	0.000598	CbGpPWpGaD
Raltitrexed—TYMS—Mitotic G1-G1/S phases—CCND1—breast cancer	2.24e-05	0.000597	CbGpPWpGaD
Raltitrexed—Dysgeusia—Epirubicin—breast cancer	2.24e-05	0.000384	CcSEcCtD
Raltitrexed—Diarrhoea—Paclitaxel—breast cancer	2.23e-05	0.000383	CcSEcCtD
Raltitrexed—FPGS—Metabolism—NQO1—breast cancer	2.22e-05	0.000591	CbGpPWpGaD
Raltitrexed—FPGS—Metabolism—SLC2A1—breast cancer	2.22e-05	0.000591	CbGpPWpGaD
Raltitrexed—FPGS—Disease—TGFBR2—breast cancer	2.21e-05	0.000589	CbGpPWpGaD
Raltitrexed—Feeling abnormal—Capecitabine—breast cancer	2.21e-05	0.000379	CcSEcCtD
Raltitrexed—Malaise—Methotrexate—breast cancer	2.2e-05	0.000378	CcSEcCtD
Raltitrexed—Gastrointestinal pain—Capecitabine—breast cancer	2.19e-05	0.000376	CcSEcCtD
Raltitrexed—Abdominal pain—Docetaxel—breast cancer	2.19e-05	0.000375	CcSEcCtD
Raltitrexed—Body temperature increased—Docetaxel—breast cancer	2.19e-05	0.000375	CcSEcCtD
Raltitrexed—Leukopenia—Methotrexate—breast cancer	2.19e-05	0.000375	CcSEcCtD
Raltitrexed—FPGS—Disease—ITPR1—breast cancer	2.18e-05	0.00058	CbGpPWpGaD
Raltitrexed—TYMS—Mitotic G1-G1/S phases—CDKN1A—breast cancer	2.17e-05	0.000578	CbGpPWpGaD
Raltitrexed—Arrhythmia—Doxorubicin—breast cancer	2.17e-05	0.000373	CcSEcCtD
Raltitrexed—FPGS—Metabolism—CYP3A4—breast cancer	2.17e-05	0.000577	CbGpPWpGaD
Raltitrexed—FPGS—Disease—ERBB4—breast cancer	2.16e-05	0.000576	CbGpPWpGaD
Raltitrexed—FPGS—Disease—STAT5A—breast cancer	2.16e-05	0.000576	CbGpPWpGaD
Raltitrexed—Alopecia—Doxorubicin—breast cancer	2.15e-05	0.000369	CcSEcCtD
Raltitrexed—TYMS—G1/S Transition—MYC—breast cancer	2.14e-05	0.000569	CbGpPWpGaD
Raltitrexed—Cough—Methotrexate—breast cancer	2.13e-05	0.000366	CcSEcCtD
Raltitrexed—FPGS—Metabolism—CYP1B1—breast cancer	2.13e-05	0.000567	CbGpPWpGaD
Raltitrexed—TYMS—Cell Cycle—TOP2A—breast cancer	2.13e-05	0.000566	CbGpPWpGaD
Raltitrexed—Ill-defined disorder—Epirubicin—breast cancer	2.12e-05	0.000364	CcSEcCtD
Raltitrexed—Body temperature increased—Capecitabine—breast cancer	2.12e-05	0.000363	CcSEcCtD
Raltitrexed—Abdominal pain—Capecitabine—breast cancer	2.12e-05	0.000363	CcSEcCtD
Raltitrexed—Anaemia—Epirubicin—breast cancer	2.11e-05	0.000363	CcSEcCtD
Raltitrexed—TYMS—Retinoblastoma (RB) in Cancer—TP53—breast cancer	2.1e-05	0.000559	CbGpPWpGaD
Raltitrexed—TYMS—Metabolism—CDA—breast cancer	2.1e-05	0.000558	CbGpPWpGaD
Raltitrexed—TYMS—Metabolism—SHMT1—breast cancer	2.1e-05	0.000558	CbGpPWpGaD
Raltitrexed—FPGS—Disease—SMAD4—breast cancer	2.09e-05	0.000558	CbGpPWpGaD
Raltitrexed—Methotrexate—ALB—breast cancer	2.09e-05	0.0106	CrCbGaD
Raltitrexed—FPGS—Metabolism—HSP90AA1—breast cancer	2.09e-05	0.000556	CbGpPWpGaD
Raltitrexed—Arthralgia—Methotrexate—breast cancer	2.08e-05	0.000357	CcSEcCtD
Raltitrexed—Vomiting—Paclitaxel—breast cancer	2.07e-05	0.000356	CcSEcCtD
Raltitrexed—Dysgeusia—Doxorubicin—breast cancer	2.07e-05	0.000356	CcSEcCtD
Raltitrexed—TYMS—Circadian rythm related genes—SERPINE1—breast cancer	2.07e-05	0.000551	CbGpPWpGaD
Raltitrexed—Malaise—Epirubicin—breast cancer	2.06e-05	0.000354	CcSEcCtD
Raltitrexed—Rash—Paclitaxel—breast cancer	2.06e-05	0.000353	CcSEcCtD
Raltitrexed—Dermatitis—Paclitaxel—breast cancer	2.05e-05	0.000353	CcSEcCtD
Raltitrexed—Discomfort—Methotrexate—breast cancer	2.05e-05	0.000353	CcSEcCtD
Raltitrexed—Leukopenia—Epirubicin—breast cancer	2.04e-05	0.000351	CcSEcCtD
Raltitrexed—FPGS—Disease—HES1—breast cancer	2.04e-05	0.000544	CbGpPWpGaD
Raltitrexed—Headache—Paclitaxel—breast cancer	2.04e-05	0.000351	CcSEcCtD
Raltitrexed—FPGS—Disease—NCOR1—breast cancer	2.03e-05	0.000541	CbGpPWpGaD
Raltitrexed—FPGS—Metabolism—NCOA1—breast cancer	2.03e-05	0.000541	CbGpPWpGaD
Raltitrexed—TYMS—Cell Cycle—AURKA—breast cancer	2.03e-05	0.00054	CbGpPWpGaD
Raltitrexed—TYMS—Metabolism—SLC2A5—breast cancer	2.02e-05	0.000538	CbGpPWpGaD
Raltitrexed—TYMS—Metabolism—SLCO1B1—breast cancer	2.02e-05	0.000538	CbGpPWpGaD
Raltitrexed—FPGS—Disease—FGF1—breast cancer	2.01e-05	0.000535	CbGpPWpGaD
Raltitrexed—FPGS—Metabolism—STK11—breast cancer	2e-05	0.000533	CbGpPWpGaD
Raltitrexed—FPGS—Metabolism—CYP19A1—breast cancer	2e-05	0.000533	CbGpPWpGaD
Raltitrexed—Methotrexate—ABCB1—breast cancer	2e-05	0.0101	CrCbGaD
Raltitrexed—FPGS—Disease—NRG1—breast cancer	2e-05	0.000531	CbGpPWpGaD
Raltitrexed—Cough—Epirubicin—breast cancer	1.99e-05	0.000342	CcSEcCtD
Raltitrexed—Asthenia—Docetaxel—breast cancer	1.98e-05	0.000341	CcSEcCtD
Raltitrexed—TYMS—Cell Cycle, Mitotic—HSP90AA1—breast cancer	1.98e-05	0.000528	CbGpPWpGaD
Raltitrexed—FPGS—Disease—H2AFX—breast cancer	1.98e-05	0.000527	CbGpPWpGaD
Raltitrexed—TYMS—Integrated Pancreatic Cancer Pathway—BCL2—breast cancer	1.98e-05	0.000527	CbGpPWpGaD
Raltitrexed—Infection—Methotrexate—breast cancer	1.98e-05	0.00034	CcSEcCtD
Raltitrexed—Ill-defined disorder—Doxorubicin—breast cancer	1.96e-05	0.000337	CcSEcCtD
Raltitrexed—Pruritus—Docetaxel—breast cancer	1.96e-05	0.000336	CcSEcCtD
Raltitrexed—Anaemia—Doxorubicin—breast cancer	1.95e-05	0.000336	CcSEcCtD
Raltitrexed—TYMS—Integrated Pancreatic Cancer Pathway—MDM2—breast cancer	1.95e-05	0.00052	CbGpPWpGaD
Raltitrexed—Thrombocytopenia—Methotrexate—breast cancer	1.95e-05	0.000335	CcSEcCtD
Raltitrexed—TYMS—Metabolism—APRT—breast cancer	1.95e-05	0.000519	CbGpPWpGaD
Raltitrexed—Arthralgia—Epirubicin—breast cancer	1.94e-05	0.000334	CcSEcCtD
Raltitrexed—TYMS—Integrated Pancreatic Cancer Pathway—RAF1—breast cancer	1.94e-05	0.000518	CbGpPWpGaD
Raltitrexed—Nausea—Paclitaxel—breast cancer	1.94e-05	0.000333	CcSEcCtD
Raltitrexed—Hyperhidrosis—Methotrexate—breast cancer	1.93e-05	0.000331	CcSEcCtD
Raltitrexed—TYMS—Integrated Pancreatic Cancer Pathway—ERBB2—breast cancer	1.92e-05	0.000512	CbGpPWpGaD
Raltitrexed—Discomfort—Epirubicin—breast cancer	1.92e-05	0.00033	CcSEcCtD
Raltitrexed—Asthenia—Capecitabine—breast cancer	1.92e-05	0.00033	CcSEcCtD
Raltitrexed—FPGS—Disease—ERCC2—breast cancer	1.91e-05	0.000509	CbGpPWpGaD
Raltitrexed—Malaise—Doxorubicin—breast cancer	1.91e-05	0.000327	CcSEcCtD
Raltitrexed—Anorexia—Methotrexate—breast cancer	1.9e-05	0.000326	CcSEcCtD
Raltitrexed—Pruritus—Capecitabine—breast cancer	1.89e-05	0.000325	CcSEcCtD
Raltitrexed—Leukopenia—Doxorubicin—breast cancer	1.89e-05	0.000325	CcSEcCtD
Raltitrexed—Diarrhoea—Docetaxel—breast cancer	1.89e-05	0.000325	CcSEcCtD
Raltitrexed—TYMS—Integrated Pancreatic Cancer Pathway—PTGS2—breast cancer	1.88e-05	0.000501	CbGpPWpGaD
Raltitrexed—FPGS—Disease—ERBB3—breast cancer	1.87e-05	0.000498	CbGpPWpGaD
Raltitrexed—FPGS—Disease—FGFR2—breast cancer	1.87e-05	0.000497	CbGpPWpGaD
Raltitrexed—Oedema—Epirubicin—breast cancer	1.86e-05	0.00032	CcSEcCtD
Raltitrexed—FPGS—Metabolism—COMT—breast cancer	1.86e-05	0.000496	CbGpPWpGaD
Raltitrexed—FPGS—Metabolism—GSTP1—breast cancer	1.85e-05	0.000493	CbGpPWpGaD
Raltitrexed—Infection—Epirubicin—breast cancer	1.85e-05	0.000318	CcSEcCtD
Raltitrexed—Cough—Doxorubicin—breast cancer	1.84e-05	0.000317	CcSEcCtD
Raltitrexed—TYMS—Metabolism—ESRRA—breast cancer	1.83e-05	0.000488	CbGpPWpGaD
Raltitrexed—TYMS—Metabolism—ANGPTL4—breast cancer	1.83e-05	0.000488	CbGpPWpGaD
Raltitrexed—Diarrhoea—Capecitabine—breast cancer	1.83e-05	0.000315	CcSEcCtD
Raltitrexed—FPGS—Metabolism—HMOX1—breast cancer	1.83e-05	0.000487	CbGpPWpGaD
Raltitrexed—Thrombocytopenia—Epirubicin—breast cancer	1.83e-05	0.000314	CcSEcCtD
Raltitrexed—FPGS—Metabolism—ITPR1—breast cancer	1.82e-05	0.000485	CbGpPWpGaD
Raltitrexed—Musculoskeletal discomfort—Methotrexate—breast cancer	1.82e-05	0.000312	CcSEcCtD
Raltitrexed—TYMS—Cell Cycle—CHEK2—breast cancer	1.81e-05	0.000483	CbGpPWpGaD
Raltitrexed—Hyperhidrosis—Epirubicin—breast cancer	1.8e-05	0.00031	CcSEcCtD
Raltitrexed—TYMS—Mitotic G1-G1/S phases—MYC—breast cancer	1.8e-05	0.000479	CbGpPWpGaD
Raltitrexed—Arthralgia—Doxorubicin—breast cancer	1.8e-05	0.000309	CcSEcCtD
Raltitrexed—FPGS—Disease—MTHFR—breast cancer	1.8e-05	0.000478	CbGpPWpGaD
Raltitrexed—FPGS—Disease—TERT—breast cancer	1.79e-05	0.000477	CbGpPWpGaD
Raltitrexed—TYMS—Integrated Pancreatic Cancer Pathway—CDKN1B—breast cancer	1.78e-05	0.000474	CbGpPWpGaD
Raltitrexed—Discomfort—Doxorubicin—breast cancer	1.78e-05	0.000305	CcSEcCtD
Raltitrexed—Anorexia—Epirubicin—breast cancer	1.78e-05	0.000305	CcSEcCtD
Raltitrexed—TYMS—Cell Cycle—HSP90AA1—breast cancer	1.77e-05	0.000472	CbGpPWpGaD
Raltitrexed—Vomiting—Docetaxel—breast cancer	1.76e-05	0.000302	CcSEcCtD
Raltitrexed—FPGS—Metabolism—ABCB1—breast cancer	1.75e-05	0.000467	CbGpPWpGaD
Raltitrexed—Dyspepsia—Methotrexate—breast cancer	1.75e-05	0.000301	CcSEcCtD
Raltitrexed—TYMS—Integrated Pancreatic Cancer Pathway—CASP3—breast cancer	1.75e-05	0.000465	CbGpPWpGaD
Raltitrexed—Rash—Docetaxel—breast cancer	1.74e-05	0.000299	CcSEcCtD
Raltitrexed—Dermatitis—Docetaxel—breast cancer	1.74e-05	0.000299	CcSEcCtD
Raltitrexed—FPGS—Disease—FGFR1—breast cancer	1.74e-05	0.000463	CbGpPWpGaD
Raltitrexed—TYMS—Metabolism—HADHB—breast cancer	1.74e-05	0.000463	CbGpPWpGaD
Raltitrexed—TYMS—Metabolism—GPI—breast cancer	1.74e-05	0.000463	CbGpPWpGaD
Raltitrexed—Decreased appetite—Methotrexate—breast cancer	1.73e-05	0.000297	CcSEcCtD
Raltitrexed—Headache—Docetaxel—breast cancer	1.73e-05	0.000297	CcSEcCtD
Raltitrexed—Oedema—Doxorubicin—breast cancer	1.73e-05	0.000296	CcSEcCtD
Raltitrexed—FPGS—Metabolism—TYMS—breast cancer	1.72e-05	0.000459	CbGpPWpGaD
Raltitrexed—Infection—Doxorubicin—breast cancer	1.71e-05	0.000294	CcSEcCtD
Raltitrexed—FPGS—Disease—HIF1A—breast cancer	1.71e-05	0.000456	CbGpPWpGaD
Raltitrexed—Pain—Methotrexate—breast cancer	1.7e-05	0.000293	CcSEcCtD
Raltitrexed—FPGS—Metabolism—PLA2G4A—breast cancer	1.7e-05	0.000453	CbGpPWpGaD
Raltitrexed—FPGS—Metabolism—GSTM1—breast cancer	1.7e-05	0.000453	CbGpPWpGaD
Raltitrexed—FPGS—Metabolism—NCOR1—breast cancer	1.7e-05	0.000453	CbGpPWpGaD
Raltitrexed—Vomiting—Capecitabine—breast cancer	1.7e-05	0.000292	CcSEcCtD
Raltitrexed—TYMS—Integrated Pancreatic Cancer Pathway—CCND1—breast cancer	1.7e-05	0.000453	CbGpPWpGaD
Raltitrexed—TYMS—Cell Cycle—BRCA1—breast cancer	1.7e-05	0.000452	CbGpPWpGaD
Raltitrexed—Musculoskeletal discomfort—Epirubicin—breast cancer	1.7e-05	0.000292	CcSEcCtD
Raltitrexed—TYMS—Integrated Pancreatic Cancer Pathway—JUN—breast cancer	1.7e-05	0.000452	CbGpPWpGaD
Raltitrexed—Thrombocytopenia—Doxorubicin—breast cancer	1.69e-05	0.00029	CcSEcCtD
Raltitrexed—Rash—Capecitabine—breast cancer	1.69e-05	0.00029	CcSEcCtD
Raltitrexed—Dermatitis—Capecitabine—breast cancer	1.69e-05	0.00029	CcSEcCtD
Raltitrexed—TYMS—Integrated Pancreatic Cancer Pathway—CTNNB1—breast cancer	1.68e-05	0.000448	CbGpPWpGaD
Raltitrexed—Headache—Capecitabine—breast cancer	1.68e-05	0.000288	CcSEcCtD
Raltitrexed—Hyperhidrosis—Doxorubicin—breast cancer	1.67e-05	0.000286	CcSEcCtD
Raltitrexed—TYMS—Cell Cycle, Mitotic—CCNE1—breast cancer	1.66e-05	0.000443	CbGpPWpGaD
Raltitrexed—TYMS—Metabolism—ALDH7A1—breast cancer	1.66e-05	0.000441	CbGpPWpGaD
Raltitrexed—TYMS—Metabolism—ALDH1A1—breast cancer	1.66e-05	0.000441	CbGpPWpGaD
Raltitrexed—FPGS—Disease—CAV1—breast cancer	1.66e-05	0.000441	CbGpPWpGaD
Raltitrexed—TYMS—Integrated Pancreatic Cancer Pathway—CDKN1A—breast cancer	1.64e-05	0.000438	CbGpPWpGaD
Raltitrexed—Anorexia—Doxorubicin—breast cancer	1.64e-05	0.000282	CcSEcCtD
Raltitrexed—Nausea—Docetaxel—breast cancer	1.64e-05	0.000282	CcSEcCtD
Raltitrexed—Feeling abnormal—Methotrexate—breast cancer	1.64e-05	0.000282	CcSEcCtD
Raltitrexed—Dyspepsia—Epirubicin—breast cancer	1.64e-05	0.000282	CcSEcCtD
Raltitrexed—TYMS—Integrated Pancreatic Cancer Pathway—PTEN—breast cancer	1.64e-05	0.000437	CbGpPWpGaD
Raltitrexed—FPGS—Metabolism—GPX1—breast cancer	1.63e-05	0.000434	CbGpPWpGaD
Raltitrexed—Gastrointestinal pain—Methotrexate—breast cancer	1.63e-05	0.00028	CcSEcCtD
Raltitrexed—TYMS—Circadian rythm related genes—JUN—breast cancer	1.63e-05	0.000434	CbGpPWpGaD
Raltitrexed—Decreased appetite—Epirubicin—breast cancer	1.62e-05	0.000278	CcSEcCtD
Raltitrexed—FPGS—Metabolism—CYP1A1—breast cancer	1.61e-05	0.00043	CbGpPWpGaD
Raltitrexed—TYMS—Integrated Pancreatic Cancer Pathway—MAPK8—breast cancer	1.61e-05	0.000427	CbGpPWpGaD
Raltitrexed—FPGS—Metabolism—ERCC2—breast cancer	1.6e-05	0.000426	CbGpPWpGaD
Raltitrexed—Constipation—Epirubicin—breast cancer	1.59e-05	0.000274	CcSEcCtD
Raltitrexed—Pain—Epirubicin—breast cancer	1.59e-05	0.000274	CcSEcCtD
Raltitrexed—Nausea—Capecitabine—breast cancer	1.59e-05	0.000273	CcSEcCtD
Raltitrexed—TYMS—Metabolism—ADSL—breast cancer	1.59e-05	0.000423	CbGpPWpGaD
Raltitrexed—TYMS—Metabolism—FHL2—breast cancer	1.59e-05	0.000423	CbGpPWpGaD
Raltitrexed—TYMS—Metabolism—NME1—breast cancer	1.59e-05	0.000423	CbGpPWpGaD
Raltitrexed—TYMS—Metabolism—PHGDH—breast cancer	1.59e-05	0.000423	CbGpPWpGaD
Raltitrexed—TYMS—Metabolism—UMPS—breast cancer	1.59e-05	0.000423	CbGpPWpGaD
Raltitrexed—TYMS—Circadian rythm related genes—PTEN—breast cancer	1.58e-05	0.000419	CbGpPWpGaD
Raltitrexed—Body temperature increased—Methotrexate—breast cancer	1.57e-05	0.000271	CcSEcCtD
Raltitrexed—Abdominal pain—Methotrexate—breast cancer	1.57e-05	0.000271	CcSEcCtD
Raltitrexed—TYMS—Cell Cycle, Mitotic—H2AFX—breast cancer	1.57e-05	0.000419	CbGpPWpGaD
Raltitrexed—Musculoskeletal discomfort—Doxorubicin—breast cancer	1.57e-05	0.00027	CcSEcCtD
Raltitrexed—TYMS—Cell Cycle, Mitotic—E2F1—breast cancer	1.56e-05	0.000416	CbGpPWpGaD
Raltitrexed—TYMS—Metabolism—LDHB—breast cancer	1.56e-05	0.000415	CbGpPWpGaD
Raltitrexed—TYMS—Metabolism—BRIP1—breast cancer	1.56e-05	0.000415	CbGpPWpGaD
Raltitrexed—TYMS—Metabolism—HPSE—breast cancer	1.56e-05	0.000415	CbGpPWpGaD
Raltitrexed—FPGS—Disease—NOS2—breast cancer	1.56e-05	0.000415	CbGpPWpGaD
Raltitrexed—FPGS—Disease—NOTCH1—breast cancer	1.54e-05	0.000411	CbGpPWpGaD
Raltitrexed—TYMS—Circadian rythm related genes—MAPK8—breast cancer	1.54e-05	0.00041	CbGpPWpGaD
Raltitrexed—TYMS—Cell Cycle—BRCA2—breast cancer	1.54e-05	0.000409	CbGpPWpGaD
Raltitrexed—Feeling abnormal—Epirubicin—breast cancer	1.54e-05	0.000264	CcSEcCtD
Raltitrexed—Gastrointestinal pain—Epirubicin—breast cancer	1.52e-05	0.000262	CcSEcCtD
Raltitrexed—TYMS—Integrated Pancreatic Cancer Pathway—SRC—breast cancer	1.52e-05	0.000405	CbGpPWpGaD
Raltitrexed—Dyspepsia—Doxorubicin—breast cancer	1.52e-05	0.000261	CcSEcCtD
Raltitrexed—FPGS—Disease—APC—breast cancer	1.51e-05	0.000402	CbGpPWpGaD
Raltitrexed—FPGS—Disease—KIT—breast cancer	1.51e-05	0.000402	CbGpPWpGaD
Raltitrexed—FPGS—Metabolism—MTHFR—breast cancer	1.5e-05	0.000401	CbGpPWpGaD
Raltitrexed—Decreased appetite—Doxorubicin—breast cancer	1.5e-05	0.000258	CcSEcCtD
Raltitrexed—FPGS—Disease—EGF—breast cancer	1.49e-05	0.000397	CbGpPWpGaD
Raltitrexed—TYMS—Cell Cycle—CCNE1—breast cancer	1.49e-05	0.000396	CbGpPWpGaD
Raltitrexed—TYMS—Integrated Pancreatic Cancer Pathway—VEGFA—breast cancer	1.48e-05	0.000395	CbGpPWpGaD
Raltitrexed—TYMS—Metabolism—GSTA3—breast cancer	1.48e-05	0.000393	CbGpPWpGaD
Raltitrexed—TYMS—Metabolism—ABCC1—breast cancer	1.48e-05	0.000393	CbGpPWpGaD
Raltitrexed—TYMS—Metabolism—HMMR—breast cancer	1.48e-05	0.000393	CbGpPWpGaD
Raltitrexed—Pain—Doxorubicin—breast cancer	1.48e-05	0.000253	CcSEcCtD
Raltitrexed—Constipation—Doxorubicin—breast cancer	1.48e-05	0.000253	CcSEcCtD
Raltitrexed—Body temperature increased—Epirubicin—breast cancer	1.47e-05	0.000253	CcSEcCtD
Raltitrexed—Abdominal pain—Epirubicin—breast cancer	1.47e-05	0.000253	CcSEcCtD
Raltitrexed—TYMS—Cell Cycle, Mitotic—BIRC5—breast cancer	1.47e-05	0.000391	CbGpPWpGaD
Raltitrexed—TYMS—Metabolism—PPARGC1B—breast cancer	1.43e-05	0.000381	CbGpPWpGaD
Raltitrexed—Asthenia—Methotrexate—breast cancer	1.43e-05	0.000246	CcSEcCtD
Raltitrexed—Feeling abnormal—Doxorubicin—breast cancer	1.42e-05	0.000244	CcSEcCtD
Raltitrexed—FPGS—Disease—BRAF—breast cancer	1.42e-05	0.000378	CbGpPWpGaD
Raltitrexed—Gastrointestinal pain—Doxorubicin—breast cancer	1.41e-05	0.000242	CcSEcCtD
Raltitrexed—Pruritus—Methotrexate—breast cancer	1.41e-05	0.000242	CcSEcCtD
Raltitrexed—TYMS—Cell Cycle—H2AFX—breast cancer	1.41e-05	0.000375	CbGpPWpGaD
Raltitrexed—TYMS—Integrated Pancreatic Cancer Pathway—MAPK3—breast cancer	1.4e-05	0.000373	CbGpPWpGaD
Raltitrexed—TYMS—Cell Cycle—E2F1—breast cancer	1.4e-05	0.000372	CbGpPWpGaD
Raltitrexed—FPGS—Metabolism—CAV1—breast cancer	1.39e-05	0.00037	CbGpPWpGaD
Raltitrexed—FPGS—Disease—AKT2—breast cancer	1.38e-05	0.000368	CbGpPWpGaD
Raltitrexed—Abdominal pain—Doxorubicin—breast cancer	1.36e-05	0.000234	CcSEcCtD
Raltitrexed—Body temperature increased—Doxorubicin—breast cancer	1.36e-05	0.000234	CcSEcCtD
Raltitrexed—TYMS—Integrated Pancreatic Cancer Pathway—MYC—breast cancer	1.36e-05	0.000363	CbGpPWpGaD
Raltitrexed—Diarrhoea—Methotrexate—breast cancer	1.36e-05	0.000234	CcSEcCtD
Raltitrexed—TYMS—Integrated Pancreatic Cancer Pathway—TGFB1—breast cancer	1.36e-05	0.000362	CbGpPWpGaD
Raltitrexed—TYMS—Metabolism—CA9—breast cancer	1.35e-05	0.00036	CbGpPWpGaD
Raltitrexed—TYMS—Metabolism—GSTA4—breast cancer	1.35e-05	0.00036	CbGpPWpGaD
Raltitrexed—TYMS—Cell Cycle, Mitotic—CDK2—breast cancer	1.35e-05	0.000359	CbGpPWpGaD
Raltitrexed—Asthenia—Epirubicin—breast cancer	1.34e-05	0.00023	CcSEcCtD
Raltitrexed—TYMS—Integrated Pancreatic Cancer Pathway—EGFR—breast cancer	1.33e-05	0.000355	CbGpPWpGaD
Raltitrexed—FPGS—Disease—PIK3CD—breast cancer	1.33e-05	0.000353	CbGpPWpGaD
Raltitrexed—Pruritus—Epirubicin—breast cancer	1.32e-05	0.000227	CcSEcCtD
Raltitrexed—TYMS—Metabolism—GSTA2—breast cancer	1.32e-05	0.000351	CbGpPWpGaD
Raltitrexed—TYMS—Metabolism—GPX2—breast cancer	1.32e-05	0.000351	CbGpPWpGaD
Raltitrexed—TYMS—Cell Cycle—BIRC5—breast cancer	1.31e-05	0.00035	CbGpPWpGaD
Raltitrexed—FPGS—Disease—SERPINE1—breast cancer	1.31e-05	0.000349	CbGpPWpGaD
Raltitrexed—TYMS—Metabolism—GPX4—breast cancer	1.3e-05	0.000346	CbGpPWpGaD
Raltitrexed—TYMS—Metabolism—SULT1A1—breast cancer	1.3e-05	0.000346	CbGpPWpGaD
Raltitrexed—Diarrhoea—Epirubicin—breast cancer	1.28e-05	0.000219	CcSEcCtD
Raltitrexed—TYMS—Cell Cycle, Mitotic—CDK4—breast cancer	1.27e-05	0.000339	CbGpPWpGaD
Raltitrexed—TYMS—Cell Cycle—TERT—breast cancer	1.27e-05	0.000339	CbGpPWpGaD
Raltitrexed—TYMS—Metabolism—GSTA1—breast cancer	1.27e-05	0.000338	CbGpPWpGaD
Raltitrexed—TYMS—Metabolism—IDH1—breast cancer	1.27e-05	0.000338	CbGpPWpGaD
Raltitrexed—TYMS—Integrated Pancreatic Cancer Pathway—TNF—breast cancer	1.27e-05	0.000338	CbGpPWpGaD
Raltitrexed—Vomiting—Methotrexate—breast cancer	1.27e-05	0.000218	CcSEcCtD
Raltitrexed—FPGS—Metabolism—PIK3CG—breast cancer	1.26e-05	0.000337	CbGpPWpGaD
Raltitrexed—TYMS—Integrated Pancreatic Cancer Pathway—KRAS—breast cancer	1.26e-05	0.000335	CbGpPWpGaD
Raltitrexed—TYMS—Metabolism—NAT2—breast cancer	1.26e-05	0.000335	CbGpPWpGaD
Raltitrexed—Rash—Methotrexate—breast cancer	1.26e-05	0.000216	CcSEcCtD
Raltitrexed—Dermatitis—Methotrexate—breast cancer	1.25e-05	0.000216	CcSEcCtD
Raltitrexed—FPGS—Disease—NOS3—breast cancer	1.25e-05	0.000334	CbGpPWpGaD
Raltitrexed—Headache—Methotrexate—breast cancer	1.25e-05	0.000214	CcSEcCtD
Raltitrexed—Asthenia—Doxorubicin—breast cancer	1.24e-05	0.000213	CcSEcCtD
Raltitrexed—Pruritus—Doxorubicin—breast cancer	1.22e-05	0.00021	CcSEcCtD
Raltitrexed—TYMS—Cell Cycle—CDK2—breast cancer	1.21e-05	0.000321	CbGpPWpGaD
Raltitrexed—FPGS—Disease—MDM2—breast cancer	1.19e-05	0.000317	CbGpPWpGaD
Raltitrexed—Vomiting—Epirubicin—breast cancer	1.19e-05	0.000204	CcSEcCtD
Raltitrexed—FPGS—Disease—RAF1—breast cancer	1.18e-05	0.000315	CbGpPWpGaD
Raltitrexed—Nausea—Methotrexate—breast cancer	1.18e-05	0.000203	CcSEcCtD
Raltitrexed—Diarrhoea—Doxorubicin—breast cancer	1.18e-05	0.000203	CcSEcCtD
Raltitrexed—Rash—Epirubicin—breast cancer	1.18e-05	0.000202	CcSEcCtD
Raltitrexed—Dermatitis—Epirubicin—breast cancer	1.17e-05	0.000202	CcSEcCtD
Raltitrexed—FPGS—Disease—ERBB2—breast cancer	1.17e-05	0.000312	CbGpPWpGaD
Raltitrexed—Headache—Epirubicin—breast cancer	1.17e-05	0.000201	CcSEcCtD
Raltitrexed—TYMS—Integrated Pancreatic Cancer Pathway—PIK3CA—breast cancer	1.16e-05	0.000308	CbGpPWpGaD
Raltitrexed—FPGS—Disease—PIK3CB—breast cancer	1.16e-05	0.000308	CbGpPWpGaD
Raltitrexed—FPGS—Disease—MTOR—breast cancer	1.16e-05	0.000308	CbGpPWpGaD
Raltitrexed—FPGS—Disease—CD4—breast cancer	1.15e-05	0.000307	CbGpPWpGaD
Raltitrexed—FPGS—Disease—PTGS2—breast cancer	1.15e-05	0.000305	CbGpPWpGaD
Raltitrexed—TYMS—Cell Cycle—ATM—breast cancer	1.14e-05	0.000305	CbGpPWpGaD
Raltitrexed—TYMS—Cell Cycle—CDK4—breast cancer	1.14e-05	0.000303	CbGpPWpGaD
Raltitrexed—TYMS—Integrated Pancreatic Cancer Pathway—TP53—breast cancer	1.12e-05	0.000298	CbGpPWpGaD
Raltitrexed—FPGS—Metabolism—PIK3CD—breast cancer	1.11e-05	0.000296	CbGpPWpGaD
Raltitrexed—TYMS—Cell Cycle, Mitotic—RB1—breast cancer	1.11e-05	0.000295	CbGpPWpGaD
Raltitrexed—Nausea—Epirubicin—breast cancer	1.11e-05	0.00019	CcSEcCtD
Raltitrexed—TYMS—Metabolism—MED12—breast cancer	1.1e-05	0.000293	CbGpPWpGaD
Raltitrexed—TYMS—Metabolism—DPYD—breast cancer	1.1e-05	0.000293	CbGpPWpGaD
Raltitrexed—FPGS—Metabolism—ALB—breast cancer	1.1e-05	0.000292	CbGpPWpGaD
Raltitrexed—Vomiting—Doxorubicin—breast cancer	1.1e-05	0.000188	CcSEcCtD
Raltitrexed—Rash—Doxorubicin—breast cancer	1.09e-05	0.000187	CcSEcCtD
Raltitrexed—Dermatitis—Doxorubicin—breast cancer	1.09e-05	0.000187	CcSEcCtD
Raltitrexed—FPGS—Disease—CDKN1B—breast cancer	1.09e-05	0.000289	CbGpPWpGaD
Raltitrexed—TYMS—Metabolism—ALDOA—breast cancer	1.08e-05	0.000289	CbGpPWpGaD
Raltitrexed—Headache—Doxorubicin—breast cancer	1.08e-05	0.000186	CcSEcCtD
Raltitrexed—TYMS—Circadian rythm related genes—TP53—breast cancer	1.07e-05	0.000286	CbGpPWpGaD
Raltitrexed—TYMS—Metabolism—NCOA3—breast cancer	1.05e-05	0.00028	CbGpPWpGaD
Raltitrexed—FPGS—Metabolism—NOS3—breast cancer	1.05e-05	0.000279	CbGpPWpGaD
Raltitrexed—TYMS—Metabolism—SLC2A2—breast cancer	1.05e-05	0.000278	CbGpPWpGaD
Raltitrexed—FPGS—Disease—CTNNB1—breast cancer	1.03e-05	0.000273	CbGpPWpGaD
Raltitrexed—Nausea—Doxorubicin—breast cancer	1.02e-05	0.000176	CcSEcCtD
Raltitrexed—TYMS—Metabolism—CPT1A—breast cancer	1.02e-05	0.000273	CbGpPWpGaD
Raltitrexed—TYMS—Metabolism—MTR—breast cancer	1.02e-05	0.000273	CbGpPWpGaD
Raltitrexed—TYMS—Metabolism—ABCG2—breast cancer	1.02e-05	0.000273	CbGpPWpGaD
Raltitrexed—TYMS—Metabolism—HPGDS—breast cancer	1e-05	0.000267	CbGpPWpGaD
Raltitrexed—FPGS—Disease—CDKN1A—breast cancer	1e-05	0.000267	CbGpPWpGaD
Raltitrexed—FPGS—Disease—PTEN—breast cancer	1e-05	0.000266	CbGpPWpGaD
Raltitrexed—TYMS—Metabolism—HBA1—breast cancer	9.98e-06	0.000266	CbGpPWpGaD
Raltitrexed—TYMS—Cell Cycle—RB1—breast cancer	9.91e-06	0.000264	CbGpPWpGaD
Raltitrexed—TYMS—Circadian rythm related genes—IL6—breast cancer	9.84e-06	0.000262	CbGpPWpGaD
Raltitrexed—TYMS—Metabolism—GSTT1—breast cancer	9.74e-06	0.000259	CbGpPWpGaD
Raltitrexed—TYMS—Metabolism—ACHE—breast cancer	9.74e-06	0.000259	CbGpPWpGaD
Raltitrexed—FPGS—Metabolism—PIK3CB—breast cancer	9.69e-06	0.000258	CbGpPWpGaD
Raltitrexed—FPGS—Metabolism—PTGS2—breast cancer	9.6e-06	0.000256	CbGpPWpGaD
Raltitrexed—TYMS—Integrated Pancreatic Cancer Pathway—AKT1—breast cancer	9.46e-06	0.000252	CbGpPWpGaD
Raltitrexed—FPGS—Disease—SRC—breast cancer	9.27e-06	0.000247	CbGpPWpGaD
Raltitrexed—TYMS—Metabolism—CYP17A1—breast cancer	9.22e-06	0.000246	CbGpPWpGaD
Raltitrexed—TYMS—Metabolism—ENO1—breast cancer	9.13e-06	0.000243	CbGpPWpGaD
Raltitrexed—TYMS—Metabolism—PTGS1—breast cancer	9.13e-06	0.000243	CbGpPWpGaD
Raltitrexed—TYMS—Metabolism—CYP2D6—breast cancer	8.95e-06	0.000238	CbGpPWpGaD
Raltitrexed—FPGS—Disease—STAT3—breast cancer	8.94e-06	0.000238	CbGpPWpGaD
Raltitrexed—TYMS—Metabolism—NCOA2—breast cancer	8.79e-06	0.000234	CbGpPWpGaD
Raltitrexed—TYMS—Cell Cycle, Mitotic—CDKN1B—breast cancer	8.63e-06	0.00023	CbGpPWpGaD
Raltitrexed—FPGS—Disease—MAPK3—breast cancer	8.54e-06	0.000227	CbGpPWpGaD
Raltitrexed—TYMS—Metabolism—FASN—breast cancer	8.52e-06	0.000227	CbGpPWpGaD
Raltitrexed—TYMS—Metabolism—BCHE—breast cancer	8.49e-06	0.000226	CbGpPWpGaD
Raltitrexed—TYMS—Cell Cycle—MDM2—breast cancer	8.45e-06	0.000225	CbGpPWpGaD
Raltitrexed—TYMS—Metabolism—SLC5A5—breast cancer	8.38e-06	0.000223	CbGpPWpGaD
Raltitrexed—FPGS—Metabolism—PTEN—breast cancer	8.37e-06	0.000223	CbGpPWpGaD
Raltitrexed—FPGS—Disease—MYC—breast cancer	8.31e-06	0.000221	CbGpPWpGaD
Raltitrexed—FPGS—Disease—TGFB1—breast cancer	8.29e-06	0.000221	CbGpPWpGaD
Raltitrexed—TYMS—Cell Cycle, Mitotic—CCND1—breast cancer	8.23e-06	0.000219	CbGpPWpGaD
Raltitrexed—FPGS—Disease—EGFR—breast cancer	8.12e-06	0.000216	CbGpPWpGaD
Raltitrexed—TYMS—Metabolism—SLC2A1—breast cancer	8.1e-06	0.000216	CbGpPWpGaD
Raltitrexed—TYMS—Metabolism—NQO1—breast cancer	8.1e-06	0.000216	CbGpPWpGaD
Raltitrexed—TYMS—Cell Cycle, Mitotic—CDKN1A—breast cancer	7.96e-06	0.000212	CbGpPWpGaD
Raltitrexed—TYMS—Metabolism—CYP3A4—breast cancer	7.9e-06	0.00021	CbGpPWpGaD
Raltitrexed—TYMS—Metabolism—CYP1B1—breast cancer	7.76e-06	0.000207	CbGpPWpGaD
Raltitrexed—TYMS—Cell Cycle—CDKN1B—breast cancer	7.71e-06	0.000205	CbGpPWpGaD
Raltitrexed—FPGS—Disease—KRAS—breast cancer	7.68e-06	0.000204	CbGpPWpGaD
Raltitrexed—TYMS—Metabolism—HSP90AA1—breast cancer	7.61e-06	0.000203	CbGpPWpGaD
Raltitrexed—TYMS—Metabolism—NCOA1—breast cancer	7.41e-06	0.000197	CbGpPWpGaD
Raltitrexed—TYMS—Cell Cycle—CCND1—breast cancer	7.36e-06	0.000196	CbGpPWpGaD
Raltitrexed—TYMS—Metabolism—CYP19A1—breast cancer	7.3e-06	0.000194	CbGpPWpGaD
Raltitrexed—TYMS—Metabolism—STK11—breast cancer	7.3e-06	0.000194	CbGpPWpGaD
Raltitrexed—TYMS—Cell Cycle—CDKN1A—breast cancer	7.12e-06	0.00019	CbGpPWpGaD
Raltitrexed—FPGS—Disease—PIK3CA—breast cancer	7.05e-06	0.000188	CbGpPWpGaD
Raltitrexed—TYMS—Cell Cycle, Mitotic—MAPK3—breast cancer	6.79e-06	0.000181	CbGpPWpGaD
Raltitrexed—TYMS—Metabolism—COMT—breast cancer	6.79e-06	0.000181	CbGpPWpGaD
Raltitrexed—TYMS—Metabolism—GSTP1—breast cancer	6.75e-06	0.00018	CbGpPWpGaD
Raltitrexed—TYMS—Metabolism—HMOX1—breast cancer	6.66e-06	0.000177	CbGpPWpGaD
Raltitrexed—TYMS—Metabolism—ITPR1—breast cancer	6.65e-06	0.000177	CbGpPWpGaD
Raltitrexed—TYMS—Cell Cycle, Mitotic—MYC—breast cancer	6.6e-06	0.000176	CbGpPWpGaD
Raltitrexed—FPGS—Disease—HRAS—breast cancer	6.52e-06	0.000174	CbGpPWpGaD
Raltitrexed—TYMS—Metabolism—ABCB1—breast cancer	6.39e-06	0.00017	CbGpPWpGaD
Raltitrexed—FPGS—Disease—IL6—breast cancer	6.24e-06	0.000166	CbGpPWpGaD
Raltitrexed—TYMS—Metabolism—GSTM1—breast cancer	6.21e-06	0.000165	CbGpPWpGaD
Raltitrexed—TYMS—Metabolism—PLA2G4A—breast cancer	6.21e-06	0.000165	CbGpPWpGaD
Raltitrexed—TYMS—Metabolism—NCOR1—breast cancer	6.21e-06	0.000165	CbGpPWpGaD
Raltitrexed—TYMS—Cell Cycle—MAPK3—breast cancer	6.07e-06	0.000162	CbGpPWpGaD
Raltitrexed—TYMS—Metabolism—GPX1—breast cancer	5.94e-06	0.000158	CbGpPWpGaD
Raltitrexed—FPGS—Metabolism—PIK3CA—breast cancer	5.91e-06	0.000157	CbGpPWpGaD
Raltitrexed—TYMS—Cell Cycle—MYC—breast cancer	5.9e-06	0.000157	CbGpPWpGaD
Raltitrexed—TYMS—Metabolism—CYP1A1—breast cancer	5.88e-06	0.000157	CbGpPWpGaD
Raltitrexed—TYMS—Metabolism—ERCC2—breast cancer	5.83e-06	0.000155	CbGpPWpGaD
Raltitrexed—FPGS—Disease—AKT1—breast cancer	5.76e-06	0.000153	CbGpPWpGaD
Raltitrexed—TYMS—Metabolism—MTHFR—breast cancer	5.48e-06	0.000146	CbGpPWpGaD
Raltitrexed—TYMS—Metabolism—CAV1—breast cancer	5.06e-06	0.000135	CbGpPWpGaD
Raltitrexed—TYMS—Cell Cycle—TP53—breast cancer	4.85e-06	0.000129	CbGpPWpGaD
Raltitrexed—FPGS—Metabolism—AKT1—breast cancer	4.82e-06	0.000128	CbGpPWpGaD
Raltitrexed—TYMS—Metabolism—PIK3CG—breast cancer	4.61e-06	0.000123	CbGpPWpGaD
Raltitrexed—TYMS—Metabolism—PIK3CD—breast cancer	4.05e-06	0.000108	CbGpPWpGaD
Raltitrexed—TYMS—Metabolism—ALB—breast cancer	4e-06	0.000106	CbGpPWpGaD
Raltitrexed—TYMS—Metabolism—NOS3—breast cancer	3.83e-06	0.000102	CbGpPWpGaD
Raltitrexed—TYMS—Metabolism—PIK3CB—breast cancer	3.53e-06	9.4e-05	CbGpPWpGaD
Raltitrexed—TYMS—Metabolism—PTGS2—breast cancer	3.5e-06	9.32e-05	CbGpPWpGaD
Raltitrexed—TYMS—Metabolism—PTEN—breast cancer	3.05e-06	8.12e-05	CbGpPWpGaD
Raltitrexed—TYMS—Metabolism—PIK3CA—breast cancer	2.15e-06	5.73e-05	CbGpPWpGaD
Raltitrexed—TYMS—Metabolism—AKT1—breast cancer	1.76e-06	4.68e-05	CbGpPWpGaD
